{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T04:32:23Z","timestamp":1785817943347,"version":"3.56.0"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12_suppl_4","content-domain":{"domain":["neurology.org"],"crossmark-restriction":true},"short-container-title":["Neurology"],"published-print":{"date-parts":[[2006,12,26]]},"DOI":"10.1212\/wnl.67.12_suppl_4.s28","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T14:42:49Z","timestamp":1336920169000},"update-policy":"https:\/\/doi.org\/10.1212\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":65,"title":["Optimizing therapy of seizures in patients with renal or hepatic dysfunction"],"prefix":"10.1212","volume":"67","author":[{"given":"Glenda","family":"Lacerda","sequence":"first","affiliation":[{"name":"From the Departments of Neurology (Drs. Lacerda, Sabourdy, and Hirsch) and Nephrology (Dr. Krummel), University Hospital of Strasbourg, France, and the Department of Functional Neurology and Epileptology (Dr. Ryvlin), Hospices Civils de Lyon, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Krummel","sequence":"additional","affiliation":[{"name":"From the Departments of Neurology (Drs. Lacerda, Sabourdy, and Hirsch) and Nephrology (Dr. Krummel), University Hospital of Strasbourg, France, and the Department of Functional Neurology and Epileptology (Dr. Ryvlin), Hospices Civils de Lyon, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ce\u0301cile","family":"Sabourdy","sequence":"additional","affiliation":[{"name":"From the Departments of Neurology (Drs. Lacerda, Sabourdy, and Hirsch) and Nephrology (Dr. Krummel), University Hospital of Strasbourg, France, and the Department of Functional Neurology and Epileptology (Dr. Ryvlin), Hospices Civils de Lyon, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Ryvlin","sequence":"additional","affiliation":[{"name":"From the Departments of Neurology (Drs. Lacerda, Sabourdy, and Hirsch) and Nephrology (Dr. Krummel), University Hospital of Strasbourg, France, and the Department of Functional Neurology and Epileptology (Dr. Ryvlin), Hospices Civils de Lyon, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edouard","family":"Hirsch","sequence":"additional","affiliation":[{"name":"From the Departments of Neurology (Drs. Lacerda, Sabourdy, and Hirsch) and Nephrology (Dr. Krummel), University Hospital of Strasbourg, France, and the Department of Functional Neurology and Epileptology (Dr. Ryvlin), Hospices Civils de Lyon, France."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","unstructured":"Aminoff MJ Parent JM. Comorbidity in adults. In: Engel J Jr Pedley TA eds. Epilepsy: a comprehensive textbook. Philadelphia: Lippincott-Raven Publishers 1997; 184 :1957\u20131959."},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajkd.2003.07.019"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V122326"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(94)00515-N"},{"key":"e_1_3_1_6_2","unstructured":"Victor M Ropper A. The acquired metabolic disorders of the nervous system. In: AH Ropper RJ Brown eds. Adams and Victor's principles of neurology. 7th ed. New York: McGraw-Hill 2001:1184\u20131190."},{"key":"e_1_3_1_7_2","first-page":"23","year":"2002","unstructured":"Palmer CA. Neurologic manifestations of renal disease. Neurol Clin 2002;20:23\u201334.","journal-title":"Neurol Clin"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(01)00767-7"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/13.10.2712"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2004.11.007"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-5231(03)00096-0"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1528-1157.2003.31402.x"},{"key":"e_1_3_1_13_2","first-page":"189","volume":"45","year":"2004","unstructured":"De Schoenmakere G, De Waele J, Terryn W, et al. Phenytoin intoxication in critically ill patients. Am J Kid Dis 2004;45:189\u2013192.","journal-title":"Am J Kid Dis"},{"key":"e_1_3_1_14_2","unstructured":"Foldavary-Shaefer N Wyllie E. Neuropharmacology of the antiepileptic drugs. In: Goetz textbook of clinical neurology. 2 nd ed. New York: Elsevier 2003:1177\u20131181."},{"key":"e_1_3_1_15_2","unstructured":"Zahiri K Launay-Vacher V Deray G. Guide de prescription des m\u00e9dicamens chez le patient insuffisant renal. Paris: Meditions International 2000."},{"key":"e_1_3_1_16_2","first-page":"986","volume":"10","year":"2002","unstructured":"Dasgupta A. Clinical utility of free drug monitoring. Clin Chem Lab Med 2002;10:986\u2013993.","journal-title":"Clin Chem Lab Med"},{"key":"e_1_3_1_17_2","first-page":"146","volume":"11","year":"1998","unstructured":"Danlami ZT, Obeid T, Awada A, et al. Absence status: an overlooked cause of acute confusion in hemodialysis patients. J Nephrol 1998;11:146\u2013147.","journal-title":"J Nephrol"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0013-9580.2005.20804.x"},{"key":"e_1_3_1_19_2","first-page":"1163","year":"2002","unstructured":"Bergin AM, Connolly M. New antiepileptic drug therapies. Neurol Clin North Am 2002;20:1163\u20131182.","journal-title":"Neurol Clin North Am"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0013-9580.2004.05504.x"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004670000535"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0013-9580.2004.30603.x"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-003-1333-8"},{"key":"e_1_3_1_24_2","first-page":"473","year":"2003","unstructured":"Ptasalos PN, Perucca E. Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs. Lancet Neurol 2003;2:473\u2013481.","journal-title":"Lancet Neurol"},{"key":"e_1_3_1_25_2","first-page":"404","year":"2003","unstructured":"Vecht CJ, Wagner GL, Wilms EB. Interactions between antiepileptics and chemotherapeutic agents. Lancet Neurol 2003;2:404\u2013409.","journal-title":"Lancet Neurol"},{"key":"e_1_3_1_26_2","first-page":"S24","volume":"63","year":"2004","unstructured":"Shet RD. Metabolic concerns associated with antiepileptic medications. Neurology 2004;63(10 suppl 4):S24\u201329.","journal-title":"Neurology"},{"key":"e_1_3_1_27_2","first-page":"S24","volume":"63","year":"2004","unstructured":"Anderson GD. Pharmacogenetics and enzyme induction\/inhibition properties of antiepileptic drugs. Neurology 2004;63(10 suppl 4):S24\u201329.","journal-title":"Neurology"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1528-1157.2003.07202.x"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000123695.22623.32"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000123693.82339.FC"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(04)00882-8"},{"key":"e_1_3_1_32_2","first-page":"446","volume":"133","year":"2003","unstructured":"T\u00fcrk-B\u00f6r\u00fc U, Ko\u00e7er A, Alp R, et al. Status epilepticus in a case of Wilson's disease during D-penicillamine treatment. Swiss Med Wkly 2003;133:446\u2013447.","journal-title":"Swiss Med Wkly"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(03)00361-0"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2006.05.004"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2006.00586.x"},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1089-3261(02)00053-3"},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0404.2003.02092.x"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000089487.42870.C6"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0749-0704(02)00051-9"},{"key":"e_1_3_1_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2004.03.017"},{"key":"e_1_3_1_41_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1528-1157.2001.44200.x"},{"key":"e_1_3_1_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2004.07.001"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.67.12_suppl_4.S28","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T12:08:23Z","timestamp":1711541303000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.67.12_suppl_4.S28"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12,26]]},"references-count":41,"journal-issue":{"issue":"12_suppl_4","published-print":{"date-parts":[[2006,12,26]]}},"alternative-id":["10.1212\/WNL.67.12_suppl_4.S28"],"URL":"https:\/\/doi.org\/10.1212\/wnl.67.12_suppl_4.s28","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,12,26]]}}}